Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: patient recorded as having no known allergies to drugs attending: chief complaint: nausea major surgical or invasive procedure: egd history of present illness: 69 yo woman with ho stage iii esophogeal carcinoma on on day 6 of cycle 2 of cisplatin/5-fu, presents with nausea, fatigue, poor po intake. describes symptoms coinciding with chemotherapy initiation. denies vomitting but reports dry heaves. patient describes herself as very weak. patient also reports intermittent upper substernal cp, associated only with eating/swallowing and relieved with gi coctail. the patient denies associated sob, fevers, chills, cough. also denies abdominal pain, diarrhea, significant weight changes, back pain. reports dysphagia, constipation, and decreased appetite. past medical history: past oncologic history: ====================== stage iii right breast cancer, diagnosed in . she was treated with a right mastectomy and adjuvant chemotherapy. she then completed five years of tamoxifen and began extended adjuvant endocrine therapy with letrozole in until present . bone, t6 vertebral body, needle core biopsy: highly suspicious for metastatic carcinoma (see note). . vertebral bone (t6), fine needle aspirate and touch prep of core biopsy: atypical. rare atypical single cells in a background of hematopoietic elements. . : a. esophageal tumor: poorly differentiated invasive carcinoma, consistent with squamous cell carcinoma. b. proximal edge of esophageal tumor at 30 cm: poorly differentiated invasive carcinoma, consistent with squamous cell carcinoma. c. antrum: antral mucosa with mild regenerative changes suggestive of chemical gastropathy. . unclear if t6 biopsy, breast cancer or esophageal cancer. tx presumptively for esophageal cancer given it is so aggressive . past medical history: ==================== onc history as detailed above hl htn, no longer requires antihypertensive medications social history: married 46 yrs, lives with husband. etoh: one drink a night before dinner tobacco: quit 15 yrs ago, smoked 20 yrs, 1ppd = 20 packyears no illicits family history: noncontributory physical exam: 97.5 110/80 82 18 98-100%ra gen: pleasant, thin elderly woman in nad, occasionally heaving during interview heent: no lad, oropharynx clear, mmm wo erythema or thrush. perrla. cv: rrr, no rmg pulm: ctab, no wrr abd: soft, ntnd, +bs, no rebound or guarding, no organomegaly ext: no edema pertinent results: glucose-172* urea n-21* creat-1.2* sodium-129* potassium-3.7 chloride-91* total co2-26 anion gap-16 calcium-8.0* phosphate-2.0* magnesium-1.3* wbc-4.9 hct-34.5* mcv-92 plt count-204 lactate-2.4* urine blood-neg nitrite-neg protein-tr glucose-100 ketone-neg bilirubin-neg urobilngn-neg ph-7.0 leuk-neg color-yellow appear-clear sp -1.010 chest (pa & lat) study date of compared to the prior study, there has been no significant interval change. a left subclavian port-a-cath is again seen with tip in the proximal superior vena cava. the lungs are clear without infiltrate or effusion. ekg: sinus tachycardia, lad, tw inversions in iii and avf, unchanged from prior ekg from . brief hospital course: 69 yo woman with ho stage iii esophogeal carcinoma on day 6 of cycle 2 of cisplatin/5-fu, presents with nausea, fatigue, poor po intake. # esophagitis: patient with signicant esophagitis. in setting of radiation tx, thrombocytopenia, pt vomitted 150cc of frank bloody emesis and was admitted to for observation. pt was transfused 1 unit prbcs and 3 units platelets and an egd showed erosive esophagitis, likely radiation induced. patient's dysphagia improved with iv pantoprazole. # pancytopenia: pt with severe thrombocytopenia requiring multiple transfusions of platelets, prbcs, and was started on neupogen which resolved her neutropenia. patient remained afebrile. # nausea: most likely combination of cisplatinum chemotoxicity causing central nausea along with constipation possibly induced by narcotics and zofran. pt is afebrile and without other sx or signs of infection. nausea was refractory and severe and needed standing zofran 8 mg iv q8h, prochlorperazine 10 mg iv q6h and reglan with eventual resolution. patient's nausea required nighttime doses which also helped her am nausea. # cp: most likely caused by esophogitis given association with eating and resolution with gi coctail. ekg normal. pt with modified well's score of 1 and low risk for pe. cardiac enzymes negative. continued home gi coctail with good effect. # dehydration: most likely due to poor po intake mostly related to chemotoxicity and dysphagia and probable component of esophogeal malignancy. pt on ivf, and this was eventually weaned off once po intake improved. # constipation: likely related to morphine and zofran. resolved with aggressive bowel regimen. # hypokalemia/hypomagnesemia: persisted despite resolution of nausea/vomitting, likely secondary to chemotoxicity. pt instructed to return to clinic within the week to check lytes. medications on admission: (all medications reconciled with patient and patient's husband). alendronate - 70 mg tablet - 1 tablet(s) by mouth once a week fentanyl - 25 mcg/hour patch 72 hr - apply to skin every 72 hours as of patient using two 25 mcg/hr patches for a total of 50 mcg/hr. letrozole - 2.5 mg tablet - 1 tablet(s) by mouth once a day lidocaine hcl - 20 mg/ml solution - apply topically q2-4 h prn lidocaine-diphenhyd--mag- - 400 mg-400 mg-40 mg-25 mg-200 mg/30 ml mouthwash - use as directed before meals as needed for mouth sores. morphine - 15 mg tablet - tablet(s) by mouth every 4-6 hours as needed for pain nystatin - 100,000 unit/ml suspension - one teaspoon by mouth four times a day retain in mouth as long as possible then swallow ondansetron - 8 mg tablet, rapid dissolve - 1 tablet(s) by mouth q8-12hrs as needed for prn nausea/vomiting oral wound care products - gel in packet - 1 gel(s) three times a day as needed for mucositis polyethylene glycol 3350 - 100 % powder - 1 powder(s) by mouth daily (daily) hold for lose stool potassium chloride - 20 meq tab sust.rel. particle/crystal - 4 tab(s) by mouth qd x 2 days followed by 2 tabs qd x 2 days prochlorperazine maleate - 10 mg tablet - 1 tablet(s) by mouth every six (6) hours as needed for nausea rosuvastatin - (prescribed by other provider) - 40 mg tablet - 1 tablet(s) by mouth once a day medications - otc ascorbic acid - 1,000 mg tablet - 1 (one) tablet(s) by mouth not taking while having chemo and radiation therapy calcium carbonate-vitamin d3 - dosage uncertain cortisone - 1 % cream - 1 cream(s) four times a day as needed for rash do not use on face docusate sodium - 100 mg capsule - 1 to 2 capsule(s) by mouth once a day as needed omeprazole - (otc) - 20 mg capsule, delayed release(e.c.) - 1 capsule(s) by mouth once a day sennosides - 8.6 mg tablet - 1 to 2 tablet(s) by mouth once a day as needed discharge medications: 1. senna 8.6 mg tablet sig: one (1) tablet po bid (2 times a day) as needed for constipation. disp:*90 tablet(s)* refills:*2* 2. fentanyl 50 mcg/hr patch 72 hr sig: one (1) patch 72 hr transdermal q72h (every 72 hours). disp:*10 patch 72 hr(s)* refills:*2* 3. calcium carbonate 500 mg tablet, chewable sig: one (1) tablet, chewable po tid (3 times a day). 4. cholecalciferol (vitamin d3) 400 unit tablet sig: one (1) tablet po daily (daily). 5. lidocaine hcl 2 % gel sig: one (1) appl mucous membrane prn (as needed) as needed for mouth pain. disp:*5 containers* refills:*2* 6. docusate sodium 50 mg/5 ml liquid sig: one (1) po bid (2 times a day) as needed for constipation. disp:*90 * refills:*2* 7. lactulose 10 gram/15 ml syrup sig: thirty (30) ml po q8h (every 8 hours) as needed for constipation. disp:*3 bottles* refills:*2* 8. bisacodyl 5 mg tablet, delayed release (e.c.) sig: two (2) tablet, delayed release (e.c.) po daily (daily) as needed for constipation. disp:*30 tablet, delayed release (e.c.)(s)* refills:*2* 9. simethicone 80 mg tablet, chewable sig: one (1) tablet, chewable po tid (3 times a day) as needed for indigestion, acid reflux. disp:*60 tablet, chewable(s)* refills:*2* 10. petrolatum ointment sig: one (1) appl topical tid (3 times a day) as needed for xrt burn. disp:*30 containers* refills:*2* 11. maalox advanced 200-200-20 mg/5 ml suspension sig: one (1) po three times a day as needed for heartburn. 12. prochlorperazine maleate 10 mg tablet sig: one (1) tablet po q6h (every 6 hours) as needed for nausea. disp:*90 tablet(s)* refills:*2* 13. metoclopramide 10 mg tablet sig: one (1) tablet po qidachs (4 times a day (before meals and at bedtime)). disp:*90 tablet(s)* refills:*2* 14. ondansetron 8 mg tablet, rapid dissolve sig: one (1) tablet, rapid dissolve po q8h (every 8 hours) as needed for nausea. disp:*90 tablet, rapid dissolve(s)* refills:*2* 15. letrozole 2.5 mg tablet sig: one (1) tablet po once a day. 16. omeprazole 20 mg capsule, delayed release(e.c.) sig: one (1) capsule, delayed release(e.c.) po once a day. 17. atenolol 25 mg tablet sig: one (1) tablet po daily (daily). disp:*30 tablet(s)* refills:*2* 18. potassium chloride 20 meq tab sust.rel. particle/crystal sig: one (1) tab sust.rel. particle/crystal po once a day for 7 days. disp:*7 tab sust.rel. particle/crystal(s)* refills:*0* 19. rosuvastatin 40 mg tablet sig: one (1) tablet po once a day. 20. morphine 15 mg tablet sig: 1-2 tablets po every 4-6 hours as needed for pain. discharge disposition: home discharge diagnosis: primary: 1) esophagitis 2) pancytopenia 3) neutropenia 4) dehydration secondary: metastatic esophogeal cancer discharge condition: stable, afebrile discharge instructions: it was a pleasure to take care of you during your hospitalization. you were admitted to the hospital for nausea, vomitting, and dehydration due to chemotoxicity. you continued to receive radiation to your esophagus during your hospital stay. you developed bloody vomitus and an upper gi scope revealed severe esophagitis secondary to radiation injury. your blood counts also suffered from the chemotherapy. we gave you platelets, red blood cells, and neupogen to stimulate your bone marrow to make neutrophils, an important white blood cell. over time your cell counts stabilized. fortunately, your ability to swallow, nausea, and vomitting improved throughout your hospital stay and you were able to take in sufficient oral intake. you also had a slightly fast heart rate. a medicaiton, atenolol, was started to control your heart rate. you also had low potassium. please take potassium as it perscribed below. you are to be discharged to home with home vna services following. we have made the following changes to your medications: 1) potassium tablet 20meq by mouth every day for 7 days or until you see your oncologist. 2) atenolol 25mg by mouth every day. 3) bisacody 10mg by mouth every day as needed for constipation 4) lactulose 30ml every 8 hours as needed for constipation 4) ondansetron odt 8mg by mouth every 8 hours for nausea 5) prochlorperazine 10mg by mouthe very 6 hours for nausea 6) metoclopramide 10mg by mouth four times a day with meals and at bedtime for nausea if you experience chest pain, shortness of breath, high fevers, please come to the emergency department. followup instructions: provider: , md phone: date/time: 3:00 you have an appointment with provider: , md phone: date/time: 2:00 you have an appointment with provider: , md phone: date/time: 2:30 you have an appointment with provider: , m.d. phone: date/time: 12:30 md procedure: other endoscopy of small intestine other radiotherapeutic procedure diagnoses: personal history of malignant neoplasm of breast hypopotassemia constipation, unspecified antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use dehydration drug induced neutropenia disorders of magnesium metabolism secondary malignant neoplasm of bone and bone marrow malignant neoplasm of other specified part of esophagus late effect of radiation radiological procedure and radiotherapy as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure other esophagitis other specified aplastic anemias 

Answer: The patient is high likely exposed to